Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2019-06-03
2020-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-stroke Fatigue, Inflammation, tDCS
NCT05330988
The Effect of Transcranial Direct Current Stimulation on Fatigue Among Multiple Sclerosis Patients.Patients
NCT05560139
The Effect of Transcranial Direct Current Stimulation for Chronic Pain on Ophthalmologic Parameters
NCT01226082
Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease
NCT01481558
Impact of Transcranial Direct Current Stimulation on Fatigability and Fatigue Induced by a Selective Attention Task
NCT02840214
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active tDCS
Patients in this group will receive 5 active sessions of low-intensity transcranial electrical stimulation for 20 minutes.
Active Transcranial Direct Current Stimulation
Subjects will undergo 5 sessions of tDCS of up to 2mA, at 20 minutes per session, 1x per day. During active stimulation, the current will be active for the full 20 minutes.
Sham tDCS
Patients in this group will receive 5 sessions of sham transcranial electrical stimulation for 20 minutes.
Sham Transcranial Direct Current Stimulation
Subjects will undergo 5 sessions of tDCS, at 20 minutes per session, 1x per day. For sham tDCS, electrodes will be placed the same way as in the intervention group, for 20 minutes. However, the stimulator will deliver 2mA of current for only 30s. The current will not be active for the rest of the 20 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Transcranial Direct Current Stimulation
Subjects will undergo 5 sessions of tDCS of up to 2mA, at 20 minutes per session, 1x per day. During active stimulation, the current will be active for the full 20 minutes.
Sham Transcranial Direct Current Stimulation
Subjects will undergo 5 sessions of tDCS, at 20 minutes per session, 1x per day. For sham tDCS, electrodes will be placed the same way as in the intervention group, for 20 minutes. However, the stimulator will deliver 2mA of current for only 30s. The current will not be active for the rest of the 20 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 65 years old;
* Diagnosis of primary Sjogren's Syndrome according to American-European Criteria;
* Stable pharmacological therapy for at least 3 months;
* Complaints of fatigue as assessed by Fatigue Severity Scale (FSS\>5).
* Complaints of fatigue for more than 3 months.
Exclusion Criteria
* Uncompensated systemic arterial hypertension;
* Unable to answer the questionnaires.
* Severe depression (with a score \> 30 in the Beck Depression Inventory)
* History of epilepsy or syncope
* Implanted brain metallic devices
* Established cognitive impairment
* Traumatic brain injury with residual neurological deficits
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
Universidade Federal do Amapá
OTHER
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana Carolina Pereira Nunes Pinto
MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana Pinto, MSc
Role: PRINCIPAL_INVESTIGATOR
Federal University of Amapa/Federal University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
FUSaoPaulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FederalUnivOfSaoPaulo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.